By The Medical College of Wisconsin
Sept. 13, 2011 |
Marcio H. Malogolowkin, M.D., has been appointed professor of pediatrics, chief of Hematology, Oncology and Bone Marrow Transplant in the department of Pediatrics, and director of the MACC Fund (Midwest Athletes Against Childhood Cancer, Inc.) Center for Cancer and Blood Disorders at the Medical College of Wisconsin. He will also serve as medical director of Hematology, Oncology and Bone Marrow Transplant at Children’s Hospital of Wisconsin – including the MACC Fund Center for Cancer and Blood Disorders, and associate director of Pediatric Oncology at the Medical College Cancer Center Dr. Malogolowkin also will be a member of the Children’s Specialty Group.
The appointment was announced jointly by Joseph E. Kerschner, M.D., interim dean and executive vice president of the Medical College, and Peggy Troy, R.N., M.S.N., president and CEO of Children’s Hospital and Health System.
Dr. Malogolowkin comes to the Medical College and Children’s Hospital from Children’s Hospital of Los Angeles, where he currently serves as head of the division of Hematology-Oncology for Clinical Affairs and Clinical Research, director of the Oncology and Bone and Soft Tissue Tumor programs, and medical director of the oncology service line. He is also an associate professor of Pediatrics and clinical scholar at the University of Southern California’s Keck School of Medicine.
His research focus is on bone and soft tissue tumors. Dr. Malogolowkin has published more than 65 manuscripts and book chapters, and given over 100 invited lectures throughout the United States and internationally. He serves as a reviewer for Pediatric Blood and Cancer, Journal of Pediatric Hematology-Oncology, Journal of Clinical Oncology, and the New England Journal of Medicine.
“Dr. Malogolowkin’s recruitment is a significant step forward for the Medical College of Wisconsin as we continue to build a world-class clinical, research and educational enterprise focused on cancer,” said Dr. Kerschner. “Dr. Malogolowkin’s nationally recognized clinical expertise in pediatric oncology and leadership skills will enable further successes in each of these areas and enhance our institutions’ ability to be at the forefront of cancer care for the citizens of Wisconsin and beyond.”
An active member of the clinical practice, he serves as a member of the Children’s Hospital of Los Angeles Medical Group (UCMG) Board of Directors and Finance Committee, and is vice-chair of the Ambulatory Care Services Committee. Nationally, he is the vice-chair of the Children’s Oncology Group (COG) Liver Tumors Subcommittee, a member of the COG Rare Tumors Committee, the COG Germ Cell Tumor Subcommittee, the COG Renal Tumors Committee, and the National Cancer Institute’s PDQ® Pediatric Cancer Treatment Advisory Board.
“I am confident Dr. Malogolowkin will take our Hematology, Oncology and Bone Marrow Transplant program to the next level in terms of clinical care, research, education, safety and quality,” said Troy. “His vast experience and passion for his work will help further elevate Children’s Hospital’s programs to national prominence. The results will be better care for infants, children, and adolescents with devastating diagnoses of cancer and blood disorders. His commitment to research will also help us continue to improve cancer survival rates so every family can have a positive outcome.”
“Dr. Malogolowkin will enhance an already outstanding group of pediatric hematologists and oncologists who are on the front lines every day saving young lives and working to defeat pediatric cancer and blood disorders, and the MACC Fund looks forward to supporting the vision and leadership he offers,” said Jan Lennon, secretary of the MACC Fund Board of Directors and a member of the search committee representing the MACC Fund. The MACC Fund is the Medical College’s largest donor and has made significant contributions to pediatric cancer and blood disorder patient care programs at Children’s Hospital.
Dr. Malogolowkin received his M.D. from the Federal University of Rio de Janeiro Medical School in Rio de Janeiro, Brazil. He completed his residency in Pediatrics at Children’s Hospital of Los Angeles, where he also completed a fellowship in Pediatric Hematology-Oncology.
His appointment is effective November 15, 2011